The NDCAs reduce the sino-atrialnodefiring rate andthe atrioventricular conduction rate because they bind more avidly to the L-type calcium channels in those cardiac cells than do the DCAs at therapeutic concentrations. Accordingly, they are considered to be rate-control CCBs.